by BSMA4 | Jan 13, 2020 | biopharma, biotech, Car-T Therapy, Supply Chain Management
By Carla Reed, president, New Creed LLC Cell and gene therapies are game changers. Critical health conditions that were once chronic or terminal are now being addressed, which is exciting news for patients and caregivers. But these therapies have a level of...
by BSMA4 | Jan 9, 2020 | Supply Chain Management
Q&A with Kevin Cast & Paul Furgal of Archbow Consulting The 12th Annual Conference of BSMA in Burlingame, CA, on October 15, brought together over 170 executives discussing Commercialization of the embryonic industry of Cell and Gene Therapy. Subsequently,...
by BSMA4 | Jan 6, 2020 | Supply Chain Management
Q&A with Mandar Paralkar, Senior Director of SAP Systems The 12th Annual Conference of BSMA in Burlingame, CA, on October 15, brought together over 170 executives discussing Commercialization of the embryonic industry of Cell and Gene Therapy. Subsequently,...
by BSMA4 | Nov 8, 2018 | Clinical Supply, commercialization, Supply Chain Management
BSMA 2018 Foster City, California Conference Proceedings Eminent executives of Life Sciences addressed how new product introduction can be enhanced by optimizing the critical transition from clinical to commercial management in the supply chain at the 11th...
by BSMA4 | Jan 26, 2018 | Block Chain
The holistic value of supply chain management has evolved in a quantum leap over the last sixty years when Jay Forrester, professor emeritus in the MIT Sloan School of Management, proposed system dynamics as a precursor to supply chain management. His first book...
